April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
Tesla Q1: Model 2 Could Be Their Model T
Tesla Is An AI Company That The Market Won’t Reward For Now
Amazon: The Margin Train Is Gaining Speed
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Aadi Bioscience (AADI) stock forecast for 2025
Updated: April 23, 2024 (17:30)
Sector: HealthcareThe share price of Aadi Bioscience, Inc. (AADI) now
50/200 Day Moving Average: $2.049 / $3.804
This figure corresponds to the Average Price over the previous 50/200 days. For Aadi Bioscience stocks, the 50-day moving average is the resistance level today.
For Aadi Bioscience stocks, the 200-day moving average is the resistance level today.
Are you interested in Aadi Bioscience, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aadi Bioscience stock price in 2025. How much will one Aadi Bioscience share be worth in 2025? Is it worth taking profit / loss on AADI stock now or waiting? What are analysts' forecasts for Aadi Bioscience stock?
We forecast Aadi Bioscience stock performance using neural networks based on historical data on AADI stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Aadi Bioscience, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Aadi Bioscience analysts is $11.67. Today 200 Day Moving Average is the resistance level (3.804 $). 50 Day Moving Average is the support level (2.049 $).
Historical and forecast chart of Aadi Bioscience, Inc. stock
The chart below shows the historical price of Aadi Bioscience stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AADI stock price can be found in the table below.
Aadi Bioscience, Inc, formerly Aerpio Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing precision therapies for genetically defined cancers. It develops therapies for cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. Its lead product, FYARROTM, is an mTOR inhibitor bound to human albumin that has tumor accumulation, mTOR target suppression, and tumor growth inhibition over other mTOR inhibitors in preclinical models2. Its nab platform allows for intratumoral drug accumulation and mTOR target suppression (pS6) at equal doses for FYARROTM vs oral mTOR inhibitors resulting in higher anti-tumor activity in animal models. Its product, FYARROTM, is in phase II registrational trial for nab-sirolimus, ABI-009 in patients with advanced perivascular epithelioid cell tumors (PEComa).
Aadi Bioscience (AADI) Forecast for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 1.85 | 1.75 | 1.93 | 9.41 % |
Feb | 1.66 | 1.48 | 1.88 | 20.92 % |
Mar | 1.60 | 1.54 | 1.72 | 10.97 % |
Apr | 1.70 | 1.43 | 1.82 | 21.16 % |
May | 2.03 | 1.87 | 2.16 | 13.53 % |
Jun | 2.34 | 2.09 | 2.70 | 22.66 % |
Jul | 2.44 | 2.25 | 2.65 | 14.76 % |
Aug | 2.56 | 2.26 | 2.88 | 21.53 % |
Sep | 2.31 | 2.10 | 2.46 | 14.82 % |
Oct | 2.42 | 2.32 | 2.65 | 12.43 % |
Nov | 2.89 | 2.73 | 3.04 | 10.44 % |
Dec | 2.85 | 2.40 | 3.12 | 23.18 % |
Aadi Bioscience information and performance
9987 CARVER ROAD, CINCINNATI, OH, US
Market capitalization of the Aadi Bioscience, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AADI shares in the company outstanding by the market price of one share.
EBITDA of Aadi Bioscience is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Aadi Bioscience price target for 2025 by month
Target values for the price of one Aadi Bioscience share for Jan 2025.
In Jan, the Negative dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 9.405% volatility is expected.
Pessimistic target level: 1.75
Optimistic target level: 1.93
Target values for the price of one Aadi Bioscience share for Feb 2025.
In Feb, the Negative dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 20.922% volatility is expected.
Pessimistic target level: 1.48
Optimistic target level: 1.88
Target values for the price of one Aadi Bioscience share for Mar 2025.
In Mar, the Negative dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 10.967% volatility is expected.
Pessimistic target level: 1.54
Optimistic target level: 1.72
Target values for the price of one Aadi Bioscience share for Apr 2025.
In Apr, the Positive dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 21.161% volatility is expected.
Pessimistic target level: 1.43
Optimistic target level: 1.82
Target values for the price of one Aadi Bioscience share for May 2025.
In May, the Positive dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 13.534% volatility is expected.
Pessimistic target level: 1.87
Optimistic target level: 2.16
Target values for the price of one Aadi Bioscience share for Jun 2025.
In Jun, the Positive dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 22.664% volatility is expected.
Pessimistic target level: 2.09
Optimistic target level: 2.70
Target values for the price of one Aadi Bioscience share for Jul 2025.
In Jul, the Positive dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 14.760% volatility is expected.
Pessimistic target level: 2.25
Optimistic target level: 2.65
Target values for the price of one Aadi Bioscience share for Aug 2025.
In Aug, the Positive dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 21.530% volatility is expected.
Pessimistic target level: 2.26
Optimistic target level: 2.88
Target values for the price of one Aadi Bioscience share for Sep 2025.
In Sep, the Negative dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 14.822% volatility is expected.
Pessimistic target level: 2.10
Optimistic target level: 2.46
Target values for the price of one Aadi Bioscience share for Oct 2025.
In Oct, the Positive dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 12.432% volatility is expected.
Pessimistic target level: 2.32
Optimistic target level: 2.65
Target values for the price of one Aadi Bioscience share for Nov 2025.
In Nov, the Positive dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 10.436% volatility is expected.
Pessimistic target level: 2.73
Optimistic target level: 3.04
Target values for the price of one Aadi Bioscience share for Dec 2025.
In Dec, the Negative dynamics for Aadi Bioscience, Inc. shares will prevail with possible monthly volatility of 23.175% volatility is expected.
Pessimistic target level: 2.40
Optimistic target level: 3.12
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.